Literature DB >> 11250189

Autotransfusion decreases blood usage following cardiac surgery -- a prospective randomized trial.

M J Dalrymple-Hay1, S Dawkins, L Pack, C D Deakin, S Sheppard, S K Ohri, M P Haw, S A Livesey, J L Monro.   

Abstract

INTRODUCTION: 10% of blood issued by the National Blood Service (220,000) is utilised in cardiac procedures. Transfusion reactions, infection risk and cost should stimulate us to decrease this transfusion rate. We tested the efficacy of autotransfusion of washed postoperative mediastinal fluid in a prospective randomized trial. PATIENTS AND METHODS: 166 patients undergoing coronary artery bypass grafting (CABG), valve or CABG + valve procedures were randomized into three groups. The indication for transfusion was a postoperative haemoglobin (Hb) < 10 g/l or a packed cell volume (PCV) < 30. When applicable, group A patients received washed post-operative drainage fluid. Group B all received blood processed from the cardiopulmonary bypass (CPB) circuit following separation from CPB and if appropriate washed post-operative drainage fluid. Group C were controls. Groups were compared using analysis of variance.
RESULTS: There was no significant difference in age, sex, type of operation, CPB time and preoperative Hb and PCV between the groups. Blood requirements were as shown. [table - see text] Twelve patients in group A and 10 in group B did not require a homologous transfusion following processing of the mediastinal drainage fluid.
CONCLUSION: Autotransfusion of washed postoperative mediastinal fluid can decrease the amount of homologous blood transfused following cardiac surgery. There was no demonstrable benefit in processing blood from the CPB circuit as well as mediastinal drainage fluid.

Entities:  

Mesh:

Year:  2001        PMID: 11250189     DOI: 10.1016/s0967-2109(00)00100-9

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  7 in total

Review 1.  Cell salvage for minimising perioperative allogeneic blood transfusion.

Authors:  Paul A Carless; David A Henry; Annette J Moxey; Dianne O'Connell; Tamara Brown; Dean A Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

2.  The Influence of Intraoperative Autotransfusion on Postoperative Hematocrit after Cardiac Surgery: A Cross-Sectional Study.

Authors:  Andrew J Stasko; Alfred H Stammers; Linda B Mongero; Eric A Tesdahl; Samuel Weinstein
Journal:  J Extra Corpor Technol       Date:  2017-12

3.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

4.  Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial.

Authors:  Jill M Cholette; Karen S Powers; George M Alfieris; Ronald Angona; Kelly F Henrichs; Debra Masel; Michael F Swartz; L Eugene Daugherty; Kevin Belmont; Neil Blumberg
Journal:  Pediatr Crit Care Med       Date:  2013-02       Impact factor: 3.624

5.  Benefit from using recycling red blood cells in cardiovascular surgery.

Authors:  Mariah Steinbach; Mauricio H Z Centenaro; Rui M S Almeida
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jul-Sep

Review 6.  Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA.

Authors:  Patrick Meybohm; Suma Choorapoikayil; Anke Wessels; Eva Herrmann; Kai Zacharowski; Donat R Spahn
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

7.  Predictors of packed red cell transfusion after isolated primary coronary artery bypass grafting--the experience of a single cardiac center: a prospective observational study.

Authors:  Elsayed M Elmistekawy; Lee Errett; Hosam F Fawzy
Journal:  J Cardiothorac Surg       Date:  2009-05-07       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.